These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15929805)

  • 61. Colorectal cancer vaccines: Tumor-associated antigens
    Wagner S; Mullins CS; Linnebacher M
    World J Gastroenterol; 2018 Dec; 24(48):5418-5432. PubMed ID: 30622371
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dendritic cell vaccination induces tumor epitope-specific Th1 immune response in medullary thyroid carcinoma.
    Papewalis C; Wuttke M; Jacobs B; Domberg J; Willenberg H; Baehring T; Cupisti K; Raffel A; Chao L; Fenk R; Seissler J; Scherbaum WA; Schott M
    Horm Metab Res; 2008 Feb; 40(2):108-16. PubMed ID: 18283628
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Human Tumor Antigens and Cancer Immunotherapy.
    Vigneron N
    Biomed Res Int; 2015; 2015():948501. PubMed ID: 26161423
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Modern Immunotherapy for the Treatment of Advanced Gastrointestinal Cancers.
    Khalil DN; Segal NH
    Oncology (Williston Park); 2016 Jan; 30(1):85-90, 93. PubMed ID: 26791849
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Immunotherapy-based combination strategies for treatment of gastrointestinal cancers: current status and future prospects.
    Zhou C; Zhang J
    Front Med; 2019 Feb; 13(1):12-23. PubMed ID: 30796606
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Immunotherapy for cancer--modern immunologic strategies in oncology].
    Halama N; Zoernig I; Jäger D
    Dtsch Med Wochenschr; 2008 Oct; 133(41):2105-8. PubMed ID: 18985564
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Progress and opportunities for immune therapeutics in osteosarcoma.
    Lettieri CK; Appel N; Labban N; Lussier DM; Blattman JN; Hingorani P
    Immunotherapy; 2016 Oct; 8(10):1233-44. PubMed ID: 27605071
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Developments in immunotherapy for gastrointestinal cancer.
    Diaz JL; Wanta SM; Fishbein TM; Kroemer A
    Minerva Chir; 2015 Aug; 70(4):217-30. PubMed ID: 25916195
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cellular immunotherapy for cancer: current concepts and clinical perspectives scientific basis and approaches for therapeutic cancer vaccines. Part I.
    Quatan N; Spicer J; Plunkett T; Pandha H
    Clin Oncol (R Coll Radiol); 2004 Aug; 16(5):356-65. PubMed ID: 15341440
    [No Abstract]   [Full Text] [Related]  

  • 70. Melanoma immunotherapy: historical precedents, recent successes and future prospects.
    Raaijmakers MI; Rozati S; Goldinger SM; Widmer DS; Dummer R; Levesque MP
    Immunotherapy; 2013 Feb; 5(2):169-82. PubMed ID: 23413908
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Translational research in melanoma.
    Tsai S; Sabel MS
    Surg Oncol Clin N Am; 2008 Apr; 17(2):391-419, ix-x. PubMed ID: 18375359
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Vaccine therapies against digestive-system cancers].
    Sakakibara M; Kanto T
    Nihon Rinsho; 2011 Sep; 69(9):1662-9. PubMed ID: 21922771
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [II.Current status of peptide vaccine for lung cancer].
    Suzuki H
    Gan To Kagaku Ryoho; 2013 Aug; 40(8):1009- 14. PubMed ID: 24151657
    [No Abstract]   [Full Text] [Related]  

  • 74. Cancer Immunotherapy: Theory and Application.
    Chen G; Bodogai M; Tamehiro N; Shen C; Dou J
    J Immunol Res; 2018; 2018():7502161. PubMed ID: 30035133
    [No Abstract]   [Full Text] [Related]  

  • 75. Personalized peptide vaccines and their relation to other therapies in urological cancer.
    Kimura T; Egawa S; Uemura H
    Nat Rev Urol; 2017 Aug; 14(8):501-510. PubMed ID: 28561807
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Cancer immunotherapy--current status].
    Kundig TM; Renner Ch; Knuth A
    Ther Umsch; 2006 Apr; 63(4):262-6. PubMed ID: 16689457
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Current status and future applications of cellular therapies for cancer.
    Copier J; Bodman-Smith M; Dalgleish A
    Immunotherapy; 2011 Apr; 3(4):507-16. PubMed ID: 21463192
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Epitope peptide vaccine with oncoantigen for cancer and its biomarker].
    Hazama S; Maeda K; Oka M
    Nihon Rinsho; 2012 Dec; 70(12):2189-93. PubMed ID: 23259395
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Immunotherapy for high-grade glioma.
    Dixit S
    Future Oncol; 2014 May; 10(6):911-5. PubMed ID: 24941977
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cancer immunotherapy.
    Schuster M; Nechansky A; Kircheis R
    Biotechnol J; 2006 Feb; 1(2):138-47. PubMed ID: 16892244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.